Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Science Translational Medicine

Topics

Computer Science

Software Engineering

Medicine

Cancer Oncology

Immunology

Show all topics

DOI

10.1126/scitranslmed.aav5989